Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1993 Nov;159(5):579–585.

Androgen deficiency and aging in men.

R S Swerdloff 1, C Wang 1
PMCID: PMC1022348  PMID: 8279155

Abstract

Androgen levels decrease with age in men. Androgen deficiency in men older than 65 years leads to asthenia, a decrease in muscle mass, osteoporosis, and a decrease in sexual activity. Androgen deficiency has been reported to cause changes in mood and cognitive function. The combination of these factors results in impaired quality of life in older men. Androgen replacement therapy in hypogonadal men increases bone and muscle mass, enhances muscle and cardiovascular function, and improves sexual function and general well-being; whether elderly men experience benefits of androgen replacement is not known. These benefits have to be weighed against the possible adverse effects of prostate and cardiovascular diseases. Careful long-term studies are needed to assess the risk-to-reward ratios of androgen or other hormone replacement therapy before treatment strategies similar to estrogen therapy for postmenopausal women are implemented.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammus S. S. The role of androgens in the treatment of hematologic disorders. Adv Intern Med. 1989;34:191–208. [PubMed] [Google Scholar]
  2. Baillie S. P., Davison C. E., Johnson F. J., Francis R. M. Pathogenesis of vertebral crush fractures in men. Age Ageing. 1992 Mar;21(2):139–141. doi: 10.1093/ageing/21.2.139. [DOI] [PubMed] [Google Scholar]
  3. Baker H. W., Burger H. G., de Kretser D. M., Hudson B., O'Connor S., Wang C., Mirovics A., Court J., Dunlop M., Rennie G. C. Changes in the pituitary-testicular system with age. Clin Endocrinol (Oxf) 1976 Jul;5(4):349–372. doi: 10.1111/j.1365-2265.1976.tb01964.x. [DOI] [PubMed] [Google Scholar]
  4. Bardin C. W., Swerdloff R. S., Santen R. J. Androgens: risks and benefits. J Clin Endocrinol Metab. 1991 Jul;73(1):4–7. doi: 10.1210/jcem-73-1-4. [DOI] [PubMed] [Google Scholar]
  5. Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med. 1992 Nov 15;117(10):807–811. doi: 10.7326/0003-4819-117-10-807. [DOI] [PubMed] [Google Scholar]
  6. Belman M. J., Gaesser G. A. Exercise training below and above the lactate threshold in the elderly. Med Sci Sports Exerc. 1991 May;23(5):562–568. [PubMed] [Google Scholar]
  7. Bevier W. C., Wiswell R. A., Pyka G., Kozak K. C., Newhall K. M., Marcus R. Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J Bone Miner Res. 1989 Jun;4(3):421–432. doi: 10.1002/jbmr.5650040318. [DOI] [PubMed] [Google Scholar]
  8. Bhasin S., Swerdloff R. S., Steiner B., Peterson M. A., Meridores T., Galmirini M., Pandian M. R., Goldberg R., Berman N. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. J Clin Endocrinol Metab. 1992 Jan;74(1):75–83. doi: 10.1210/jcem.74.1.1727832. [DOI] [PubMed] [Google Scholar]
  9. Bremner W. J., Vitiello M. V., Prinz P. N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab. 1983 Jun;56(6):1278–1281. doi: 10.1210/jcem-56-6-1278. [DOI] [PubMed] [Google Scholar]
  10. Christiansen K., Knussmann R. Sex hormones and cognitive functioning in men. Neuropsychobiology. 1987;18(1):27–36. doi: 10.1159/000118389. [DOI] [PubMed] [Google Scholar]
  11. Colvard D. S., Eriksen E. F., Keeting P. E., Wilson E. M., Lubahn D. B., French F. S., Riggs B. L., Spelsberg T. C. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci U S A. 1989 Feb;86(3):854–857. doi: 10.1073/pnas.86.3.854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Copeland K. C., Colletti R. B., Devlin J. T., McAuliffe T. L. The relationship between insulin-like growth factor-I, adiposity, and aging. Metabolism. 1990 Jun;39(6):584–587. doi: 10.1016/0026-0495(90)90022-5. [DOI] [PubMed] [Google Scholar]
  13. Craig B. W., Brown R., Everhart J. Effects of progressive resistance training on growth hormone and testosterone levels in young and elderly subjects. Mech Ageing Dev. 1989 Aug;49(2):159–169. doi: 10.1016/0047-6374(89)90099-7. [DOI] [PubMed] [Google Scholar]
  14. Davidson J. M., Camargo C. A., Smith E. R. Effects of androgen on sexual behavior in hypogonadal men. J Clin Endocrinol Metab. 1979 Jun;48(6):955–958. doi: 10.1210/jcem-48-6-955. [DOI] [PubMed] [Google Scholar]
  15. Davidson J. M., Chen J. J., Crapo L., Gray G. D., Greenleaf W. J., Catania J. A. Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab. 1983 Jul;57(1):71–77. doi: 10.1210/jcem-57-1-71. [DOI] [PubMed] [Google Scholar]
  16. Deslypere J. P., Kaufman J. M., Vermeulen T., Vogelaers D., Vandalem J. L., Vermeulen A. Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. J Clin Endocrinol Metab. 1987 Jan;64(1):68–73. doi: 10.1210/jcem-64-1-68. [DOI] [PubMed] [Google Scholar]
  17. Deslypere J. P., Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. J Clin Endocrinol Metab. 1984 Nov;59(5):955–962. doi: 10.1210/jcem-59-5-955. [DOI] [PubMed] [Google Scholar]
  18. Diamond T., Stiel D., Posen S. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 1991 Jan;6(1):39–43. doi: 10.1002/jbmr.5650060108. [DOI] [PubMed] [Google Scholar]
  19. FORBES G. B., HURSH J. B. AGE AND SEX TRENDS IN LEAN BODY MASS CALCULATED FROM K40 MEASUREMENTS: WITH A NOTE ON THE THEORETICAL BASIS FOR THE PROCEDURE. Ann N Y Acad Sci. 1963 Sep 26;110:255–263. doi: 10.1111/j.1749-6632.1963.tb17090.x. [DOI] [PubMed] [Google Scholar]
  20. Farmer M. E., White L. R., Brody J. A., Bailey K. R. Race and sex differences in hip fracture incidence. Am J Public Health. 1984 Dec;74(12):1374–1380. doi: 10.2105/ajph.74.12.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Finkelstein J. S., Klibanski A., Neer R. M., Doppelt S. H., Rosenthal D. I., Segre G. V., Crowley W. F., Jr Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989 Oct;69(4):776–783. doi: 10.1210/jcem-69-4-776. [DOI] [PubMed] [Google Scholar]
  22. Finkelstein J. S., Klibanski A., Neer R. M., Greenspan S. L., Rosenthal D. I., Crowley W. F., Jr Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987 Mar;106(3):354–361. doi: 10.7326/0003-4819-106-3-. [DOI] [PubMed] [Google Scholar]
  23. Florini J. R., Prinz P. N., Vitiello M. V., Hintz R. L. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol. 1985 Jan;40(1):2–7. doi: 10.1093/geronj/40.1.2. [DOI] [PubMed] [Google Scholar]
  24. Flynn M. A., Nolph G. B., Baker A. S., Martin W. M., Krause G. Total body potassium in aging humans: a longitudinal study. Am J Clin Nutr. 1989 Oct;50(4):713–717. doi: 10.1093/ajcn/50.4.713. [DOI] [PubMed] [Google Scholar]
  25. Foresta C., Ruzza G., Mioni R., Guarneri G., Gribaldo R., Meneghello A., Mastrogiacomo I. Osteoporosis and decline of gonadal function in the elderly male. Horm Res. 1984;19(1):18–22. doi: 10.1159/000179855. [DOI] [PubMed] [Google Scholar]
  26. Francis R. M., Peacock M., Aaron J. E., Selby P. L., Taylor G. A., Thompson J., Marshall D. H., Horsman A. Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone. 1986;7(4):261–268. doi: 10.1016/8756-3282(86)90205-x. [DOI] [PubMed] [Google Scholar]
  27. Friedl K. E., Hannan C. J., Jr, Jones R. E., Plymate S. R. High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism. 1990 Jan;39(1):69–74. doi: 10.1016/0026-0495(90)90150-b. [DOI] [PubMed] [Google Scholar]
  28. Friedl K. E., Jones R. E., Hannan C. J., Jr, Plymate S. R. The administration of pharmacological doses of testosterone or 19-nortestosterone to normal men is not associated with increased insulin secretion or impaired glucose tolerance. J Clin Endocrinol Metab. 1989 May;68(5):971–975. doi: 10.1210/jcem-68-5-971. [DOI] [PubMed] [Google Scholar]
  29. Fukayama S., Tashjian A. H., Jr Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 1989 Oct;125(4):1789–1794. doi: 10.1210/endo-125-4-1789. [DOI] [PubMed] [Google Scholar]
  30. Gray A., Berlin J. A., McKinlay J. B., Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol. 1991;44(7):671–684. doi: 10.1016/0895-4356(91)90028-8. [DOI] [PubMed] [Google Scholar]
  31. Gray A., Feldman H. A., McKinlay J. B., Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991 Nov;73(5):1016–1025. doi: 10.1210/jcem-73-5-1016. [DOI] [PubMed] [Google Scholar]
  32. Greenspan S. L., Neer R. M., Ridgway E. C., Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1986 Jun;104(6):777–782. doi: 10.7326/0003-4819-104-6-777. [DOI] [PubMed] [Google Scholar]
  33. Griggs R. C., Kingston W., Jozefowicz R. F., Herr B. E., Forbes G., Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol (1985) 1989 Jan;66(1):498–503. doi: 10.1152/jappl.1989.66.1.498. [DOI] [PubMed] [Google Scholar]
  34. Harman S. M., Tsitouras P. D., Costa P. T., Blackman M. R. Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab. 1982 Mar;54(3):547–551. doi: 10.1210/jcem-54-3-547. [DOI] [PubMed] [Google Scholar]
  35. Harman S. M., Tsitouras P. D. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab. 1980 Jul;51(1):35–40. doi: 10.1210/jcem-51-1-35. [DOI] [PubMed] [Google Scholar]
  36. Jackson J. A., Kleerekoper M., Parfitt A. M., Rao D. S., Villanueva A. R., Frame B. Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. J Clin Endocrinol Metab. 1987 Jul;65(1):53–58. doi: 10.1210/jcem-65-1-53. [DOI] [PubMed] [Google Scholar]
  37. Johnson L. Spermatogenesis and aging in the human. J Androl. 1986 Nov-Dec;7(6):331–354. doi: 10.1002/j.1939-4640.1986.tb00943.x. [DOI] [PubMed] [Google Scholar]
  38. Kasperk C. H., Wergedal J. E., Farley J. R., Linkhart T. A., Turner R. T., Baylink D. J. Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 1989 Mar;124(3):1576–1578. doi: 10.1210/endo-124-3-1576. [DOI] [PubMed] [Google Scholar]
  39. Kelly P. J., Pocock N. A., Sambrook P. N., Eisman J. A. Dietary calcium, sex hormones, and bone mineral density in men. BMJ. 1990 May 26;300(6736):1361–1364. doi: 10.1136/bmj.300.6736.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Korenman S. G., Morley J. E., Mooradian A. D., Davis S. S., Kaiser F. E., Silver A. J., Viosca S. P., Garza D. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab. 1990 Oct;71(4):963–969. doi: 10.1210/jcem-71-4-963. [DOI] [PubMed] [Google Scholar]
  41. Kraemer W. J., Gordon S. E., Fleck S. J., Marchitelli L. J., Mello R., Dziados J. E., Friedl K., Harman E., Maresh C., Fry A. C. Endogenous anabolic hormonal and growth factor responses to heavy resistance exercise in males and females. Int J Sports Med. 1991 Apr;12(2):228–235. doi: 10.1055/s-2007-1024673. [DOI] [PubMed] [Google Scholar]
  42. Krauss D. J., Taub H. A., Lantinga L. J., Dunsky M. H., Kelly C. M. Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol. 1991 Dec;146(6):1566–1570. doi: 10.1016/s0022-5347(17)38168-5. [DOI] [PubMed] [Google Scholar]
  43. Lamberts S. W., Valk N. K., Binnerts A. The use of growth hormone in adults: a changing scene. Clin Endocrinol (Oxf) 1992 Aug;37(2):111–115. doi: 10.1111/j.1365-2265.1992.tb02293.x. [DOI] [PubMed] [Google Scholar]
  44. Liu L., Merriam G. R., Sherins R. J. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1987 Apr;64(4):651–656. doi: 10.1210/jcem-64-4-651. [DOI] [PubMed] [Google Scholar]
  45. MENEELY G. R., HEYSSEL R. M., BALL C. O., WEILAND R. L., LORIMER A. R., CONSTANTINIDES C., MENEELY E. U. ANALYSIS OF FACTORS AFFECTING BODY COMPOSITION DETERMINED FROM POTASSIUM CONTENT IN 915 NORMAL SUBJECTS. Ann N Y Acad Sci. 1963 Sep 26;110:271–281. doi: 10.1111/j.1749-6632.1963.tb17092.x. [DOI] [PubMed] [Google Scholar]
  46. Matsumoto A. M., Sandblom R. E., Schoene R. B., Lee K. A., Giblin E. C., Pierson D. J., Bremner W. J. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clin Endocrinol (Oxf) 1985 Jun;22(6):713–721. doi: 10.1111/j.1365-2265.1985.tb00161.x. [DOI] [PubMed] [Google Scholar]
  47. McConnell J. D. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia. Urol Clin North Am. 1990 Aug;17(3):661–670. [PubMed] [Google Scholar]
  48. Meier D. E., Orwoll E. S., Jones J. M. Marked disparity between trabecular and cortical bone loss with age in healthy men. Measurement by vertebral computed tomography and radial photon absorptiometry. Ann Intern Med. 1984 Nov;101(5):605–612. doi: 10.7326/0003-4819-101-5-605. [DOI] [PubMed] [Google Scholar]
  49. Mineau G. P., Trussell J. A specification of marital fertility by parents' age, age at marriage and marital duration. Demography. 1982 Aug;19(3):335–350. [PubMed] [Google Scholar]
  50. Mooradian A. D., Morley J. E., Korenman S. G. Biological actions of androgens. Endocr Rev. 1987 Feb;8(1):1–28. doi: 10.1210/edrv-8-1-1. [DOI] [PubMed] [Google Scholar]
  51. Nankin H. R., Calkins J. H. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab. 1986 Dec;63(6):1418–1420. doi: 10.1210/jcem-63-6-1418. [DOI] [PubMed] [Google Scholar]
  52. Nieschlag E., Lammers U., Freischem C. W., Langer K., Wickings E. J. Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab. 1982 Oct;55(4):676–681. doi: 10.1210/jcem-55-4-676. [DOI] [PubMed] [Google Scholar]
  53. O'Carroll R., Bancroft J. Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study. Br J Psychiatry. 1984 Aug;145:146–151. doi: 10.1192/bjp.145.2.146. [DOI] [PubMed] [Google Scholar]
  54. Orwoll E. S., Oviatt S. K., Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab. 1990 Apr;70(4):1202–1207. doi: 10.1210/jcem-70-4-1202. [DOI] [PubMed] [Google Scholar]
  55. Orwoll E. S., Oviatt S. K., McClung M. R., Deftos L. J., Sexton G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann Intern Med. 1990 Jan 1;112(1):29–34. doi: 10.7326/0003-4819-112-1-29. [DOI] [PubMed] [Google Scholar]
  56. Palacios A., Campfield L. A., McClure R. D., Steiner B., Swerdloff R. S. Effect of testosterone enanthate on hematopoiesis in normal men. Fertil Steril. 1983 Jul;40(1):100–104. doi: 10.1016/s0015-0282(16)47185-2. [DOI] [PubMed] [Google Scholar]
  57. Pavlov E. P., Harman S. M., Merriam G. R., Gelato M. C., Blackman M. R. Responses of growth hormone (GH) and somatomedin-C to GH-releasing hormone in healthy aging men. J Clin Endocrinol Metab. 1986 Mar;62(3):595–600. doi: 10.1210/jcem-62-3-595. [DOI] [PubMed] [Google Scholar]
  58. Pirke K. M., Doerr P. Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. Acta Endocrinol (Copenh) 1975 Sep;80(1):171–178. doi: 10.1530/acta.0.0800171. [DOI] [PubMed] [Google Scholar]
  59. Poehlman E. T., Copeland K. C. Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab. 1990 Dec;71(6):1468–1473. doi: 10.1210/jcem-71-6-1468. [DOI] [PubMed] [Google Scholar]
  60. Prince R. L., Smith M., Dick I. M., Price R. I., Webb P. G., Henderson N. K., Harris M. M. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N Engl J Med. 1991 Oct 24;325(17):1189–1195. doi: 10.1056/NEJM199110243251701. [DOI] [PubMed] [Google Scholar]
  61. Pyka G., Wiswell R. A., Marcus R. Age-dependent effect of resistance exercise on growth hormone secretion in people. J Clin Endocrinol Metab. 1992 Aug;75(2):404–407. doi: 10.1210/jcem.75.2.1639942. [DOI] [PubMed] [Google Scholar]
  62. Reed R. L., Pearlmutter L., Yochum K., Meredith K. E., Mooradian A. D. The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc. 1991 Jun;39(6):555–561. doi: 10.1111/j.1532-5415.1991.tb03592.x. [DOI] [PubMed] [Google Scholar]
  63. Riggs B. L., Wahner H. W., Dunn W. L., Mazess R. B., Offord K. P., Melton L. J., 3rd Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest. 1981 Feb;67(2):328–335. doi: 10.1172/JCI110039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Rubens R., Dhont M., Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endocrinol Metab. 1974 Jul;39(1):40–45. doi: 10.1210/jcem-39-1-40. [DOI] [PubMed] [Google Scholar]
  65. Rudman D., Feller A. G., Nagraj H. S., Gergans G. A., Lalitha P. Y., Goldberg A. F., Schlenker R. A., Cohn L., Rudman I. W., Mattson D. E. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5;323(1):1–6. doi: 10.1056/NEJM199007053230101. [DOI] [PubMed] [Google Scholar]
  66. Rudman D. Growth hormone, body composition, and aging. J Am Geriatr Soc. 1985 Nov;33(11):800–807. doi: 10.1111/j.1532-5415.1985.tb04195.x. [DOI] [PubMed] [Google Scholar]
  67. Rudman D., Kutner M. H., Rogers C. M., Lubin M. F., Fleming G. A., Bain R. P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest. 1981 May;67(5):1361–1369. doi: 10.1172/JCI110164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Sakamoto K., Wakabayashi I., Yoshimoto S., Masui H., Katsuno S. Effects of physical exercise and cold stimulation on serum testosterone level in men. Nihon Eiseigaku Zasshi. 1991 Jun;46(2):635–638. doi: 10.1265/jjh.46.635. [DOI] [PubMed] [Google Scholar]
  69. Santavirta S., Konttinen Y. T., Heliövaara M., Knekt P., Lüthje P., Aromaa A. Determinants of osteoporotic thoracic vertebral fracture. Screening of 57,000 Finnish women and men. Acta Orthop Scand. 1992 Apr;63(2):198–202. doi: 10.3109/17453679209154823. [DOI] [PubMed] [Google Scholar]
  70. Seeman E., Melton L. J., 3rd, O'Fallon W. M., Riggs B. L. Risk factors for spinal osteoporosis in men. Am J Med. 1983 Dec;75(6):977–983. doi: 10.1016/0002-9343(83)90878-1. [DOI] [PubMed] [Google Scholar]
  71. Sherwin B. B., Gelfand M. M. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1987 Jul-Aug;49(4):397–409. doi: 10.1097/00006842-198707000-00009. [DOI] [PubMed] [Google Scholar]
  72. Sinaki M. Exercise and osteoporosis. Arch Phys Med Rehabil. 1989 Mar;70(3):220–229. [PubMed] [Google Scholar]
  73. Snow-Harter C., Bouxsein M., Lewis B., Charette S., Weinstein P., Marcus R. Muscle strength as a predictor of bone mineral density in young women. J Bone Miner Res. 1990 Jun;5(6):589–595. doi: 10.1002/jbmr.5650050608. [DOI] [PubMed] [Google Scholar]
  74. Sparrow D., Bosse R., Rowe J. W. The influence of age, alcohol consumption, and body build on gonadal function in men. J Clin Endocrinol Metab. 1980 Sep;51(3):508–512. doi: 10.1210/jcem-51-3-508. [DOI] [PubMed] [Google Scholar]
  75. Stanley H. L., Schmitt B. P., Poses R. M., Deiss W. P. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? J Am Geriatr Soc. 1991 Aug;39(8):766–771. doi: 10.1111/j.1532-5415.1991.tb02698.x. [DOI] [PubMed] [Google Scholar]
  76. Stearns E. L., MacDonnell J. A., Kaufman B. J., Padua R., Lucman T. S., Winter J. S., Faiman C. Declining testicular function with age. Hormonal and clinical correlates. Am J Med. 1974 Nov;57(5):761–766. doi: 10.1016/0002-9343(74)90850-x. [DOI] [PubMed] [Google Scholar]
  77. Stepán J. J., Lachman M., Zverina J., Pacovský V., Baylink D. J. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989 Sep;69(3):523–527. doi: 10.1210/jcem-69-3-523. [DOI] [PubMed] [Google Scholar]
  78. Tenover J. S., Dahl K. D., Hsueh A. J., Lim P., Matsumoto A. M., Bremner W. J. Serum bioactive and immunoreactive follicle-stimulating hormone levels and the response to clomiphene in healthy young and elderly men. J Clin Endocrinol Metab. 1987 Jun;64(6):1103–1108. doi: 10.1210/jcem-64-6-1103. [DOI] [PubMed] [Google Scholar]
  79. Tenover J. S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992 Oct;75(4):1092–1098. doi: 10.1210/jcem.75.4.1400877. [DOI] [PubMed] [Google Scholar]
  80. Thompson P. D., Cullinane E. M., Sady S. P., Chenevert C., Saritelli A. L., Sady M. A., Herbert P. N. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989 Feb 24;261(8):1165–1168. [PubMed] [Google Scholar]
  81. Tsitouras P. D. Effects of age on testicular function. Endocrinol Metab Clin North Am. 1987 Dec;16(4):1045–1059. [PubMed] [Google Scholar]
  82. Ulloa-Aguirre A., Blizzard R. M., Garcia-Rubi E., Rogol A. D., Link K., Christie C. M., Johnson M. L., Veldhuis J. D. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab. 1990 Oct;71(4):846–854. doi: 10.1210/jcem-71-4-846. [DOI] [PubMed] [Google Scholar]
  83. Vermeulen A. Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab. 1991 Aug;73(2):221–224. doi: 10.1210/jcem-73-2-221. [DOI] [PubMed] [Google Scholar]
  84. Vermeulen A. Nyctohemeral growth hormone profiles in young and aged men: correlation with somatomedin-C levels. J Clin Endocrinol Metab. 1987 May;64(5):884–888. doi: 10.1210/jcem-64-5-884. [DOI] [PubMed] [Google Scholar]
  85. Vermeulen A., Rubens R., Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab. 1972 Apr;34(4):730–735. doi: 10.1210/jcem-34-4-730. [DOI] [PubMed] [Google Scholar]
  86. Warner B. A., Dufau M. L., Santen R. J. Effects of aging and illness on the pituitary testicular axis in men: qualitative as well as quantitative changes in luteinizing hormone. J Clin Endocrinol Metab. 1985 Feb;60(2):263–268. doi: 10.1210/jcem-60-2-263. [DOI] [PubMed] [Google Scholar]
  87. Welle S., Jozefowicz R., Forbes G., Griggs R. C. Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy. J Clin Endocrinol Metab. 1992 Feb;74(2):332–335. doi: 10.1210/jcem.74.2.1730811. [DOI] [PubMed] [Google Scholar]
  88. Wilson J. D. Androgen abuse by athletes. Endocr Rev. 1988 May;9(2):181–199. doi: 10.1210/edrv-9-2-181. [DOI] [PubMed] [Google Scholar]
  89. Winters S. J., Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab. 1982 Sep;55(3):560–565. doi: 10.1210/jcem-55-3-560. [DOI] [PubMed] [Google Scholar]
  90. Zumoff B., Strain G. W., Kream J., O'Connor J., Rosenfeld R. S., Levin J., Fukushima D. K. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men. J Clin Endocrinol Metab. 1982 Mar;54(3):534–538. doi: 10.1210/jcem-54-3-534. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES